{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T21:53:21Z","timestamp":1784843601431,"version":"3.55.0"},"reference-count":36,"publisher":"European Respiratory Society (ERS)","issue":"4","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","award":["1199-0439"],"award-info":[{"award-number":["1199-0439"]}],"id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["ERJ Open Res"],"accepted":{"date-parts":[[2022,8,18]]},"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>This multicentre, international, prospective cohort study evaluated whether patients with pulmonary sarcoidosis living in neighbourhoods with greater material and social disadvantage experience worse clinical outcomes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The area deprivation index and the Canadian Index of Multiple Deprivation evaluate neighbourhood-level disadvantage in the US and Canada, with higher scores reflecting greater disadvantage. Multivariable linear regression evaluated associations of disadvantage with baseline forced vital capacity (FVC) or diffusing capacity of the lung for carbon monoxide (<jats:italic>D<\/jats:italic><jats:sub>LCO<\/jats:sub>) and linear mixed effects models for associations with rate of FVC or<jats:italic>D<\/jats:italic><jats:sub>LCO<\/jats:sub>decline, and competing hazards models were used for survival analyses in the US cohort, evaluating competing outcomes of death or lung transplantation. Adjustments were made for age at diagnosis, sex, race and smoking history.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We included 477 US and 122 Canadian patients with sarcoidosis. Higher disadvantage was not associated with survival or baseline FVC. The highest disadvantage quartile was associated with lower baseline<jats:italic>D<\/jats:italic><jats:sub>LCO<\/jats:sub>in the US cohort (\u03b2\u2005=\u2005\u22126.80, 95% CI \u221213.16 to \u22120.44, p=0.04), with similar findings in the Canadian cohort (\u03b2\u2005=\u2005\u22127.47, 95% CI \u221220.28 to 5.33, p=0.25); with more rapid decline in FVC and<jats:italic>D<\/jats:italic><jats:sub>LCO<\/jats:sub>in the US cohort (FVC \u03b2\u2005=\u2005\u22120.40, 95% CI \u22120.70 to \u22120.11, p=0.007;<jats:italic>D<\/jats:italic><jats:sub>LCO<\/jats:sub>\u03b2\u2005=\u2005\u22120.59, 95% CI \u22120.95 to \u22120.23, p=0.001); and with more rapid FVC decline in the Canadian cohort (FVC \u03b2\u2005=\u2005\u22120.80, 95% CI \u22121.37 to \u22120.24, p=0.003).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Patients with sarcoidosis living in high disadvantage neighbourhoods experience worse baseline lung function and more rapid lung function decline, highlighting the need for better understanding of how neighbourhood-level factors impact individual patient outcomes.<\/jats:p><\/jats:sec>","DOI":"10.1183\/23120541.00357-2022","type":"journal-article","created":{"date-parts":[[2022,10,13]],"date-time":"2022-10-13T14:15:49Z","timestamp":1665670549000},"page":"00357-2022","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Neighbourhood disadvantage impacts on pulmonary function in patients with sarcoidosis"],"prefix":"10.1183","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7982-5635","authenticated-orcid":false,"given":"Gillian C.","family":"Goobie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Ryerson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1205-5511","authenticated-orcid":false,"given":"Kerri A.","family":"Johannson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spencer","family":"Keil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Schikowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasreen","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Marcoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Assayag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Manganas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolene H.","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3837-1467","authenticated-orcid":false,"given":"Martin R.J.","family":"Kolb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin F.","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6597-7830","authenticated-orcid":false,"given":"Daniel J.","family":"Kass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6947-2901","authenticated-orcid":false,"given":"Yingze","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen O.","family":"Lindell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Mehdi","family":"Nouraie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2022,10,13]]},"reference":[{"key":"2024101711414114000_8.4.00357-2022.1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00991-2017"},{"key":"2024101711414114000_8.4.00357-2022.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2015.10.024"},{"key":"2024101711414114000_8.4.00357-2022.3","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.160.2.ats4-99"},{"key":"2024101711414114000_8.4.00357-2022.4","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201511-760OC"},{"key":"2024101711414114000_8.4.00357-2022.5","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00444-2019"},{"key":"2024101711414114000_8.4.00357-2022.6","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.04.00070503"},{"key":"2024101711414114000_8.4.00357-2022.7","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.rmed.2018.11.010","article-title":"Sarcoidosis deaths in the United States: 1999\u20132016","volume":"149","author":"Kearney","year":"2019","journal-title":"Respir Med"},{"key":"2024101711414114000_8.4.00357-2022.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2017.07.008"},{"key":"2024101711414114000_8.4.00357-2022.9","doi-asserted-by":"publisher","DOI":"10.1378\/chest.14-1120"},{"key":"2024101711414114000_8.4.00357-2022.10","doi-asserted-by":"crossref","first-page":"537382","DOI":"10.3389\/fimmu.2020.537382","article-title":"Sarcoidosis epidemiology: race matters","volume":"11","author":"Hena","year":"2020","journal-title":"Front Immunol"},{"key":"2024101711414114000_8.4.00357-2022.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccm.2006.04.002"},{"key":"2024101711414114000_8.4.00357-2022.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcna.2005.02.006"},{"key":"2024101711414114000_8.4.00357-2022.13","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1164\/rccm.201906-1250OC","article-title":"Income and other contributors to poor outcomes in U.S. patients with sarcoidosis","volume":"201","author":"Harper","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"2024101711414114000_8.4.00357-2022.14","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.01.00056201"},{"key":"2024101711414114000_8.4.00357-2022.15","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/MCP.0000000000000704","article-title":"Socioeconomic determinants and disparities in sarcoidosis","volume":"26","author":"Sharp","year":"2020","journal-title":"Curr Opin Pulm Med"},{"key":"2024101711414114000_8.4.00357-2022.16","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1513\/AnnalsATS.201707-564OT","article-title":"Disease burden and variability in sarcoidosis","volume":"14","author":"Gerke","year":"2017","journal-title":"Ann Am Thorac Soc"},{"key":"2024101711414114000_8.4.00357-2022.17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1802313"},{"key":"2024101711414114000_8.4.00357-2022.18","doi-asserted-by":"crossref","first-page":"e285","DOI":"10.1097\/INF.0000000000002419","article-title":"Area deprivation as a risk factor for methicillin-resistant Staphylococcus aureus infection in pediatric cystic fibrosis","volume":"38","author":"Oates","year":"2019","journal-title":"Pediatr Infect Dis J"},{"key":"2024101711414114000_8.4.00357-2022.19","doi-asserted-by":"crossref","first-page":"981","DOI":"10.2147\/COPD.S238933","article-title":"The association between neighborhood socioeconomic disadvantage and chronic obstructive pulmonary disease","volume":"15","author":"Galiatsatos","year":"2020","journal-title":"Int J Chron Obs Pulmon Dis"},{"key":"2024101711414114000_8.4.00357-2022.20","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1164\/rccm.202002-0253OC","article-title":"Contribution of individual and neighborhood factors to racial disparities in respiratory outcomes","volume":"203","author":"Ejike","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"2024101711414114000_8.4.00357-2022.21","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1164\/rccm.202109-2065OC","article-title":"Neighborhood-level disadvantage impacts on patients with fibrotic interstitial lung disease","volume":"205","author":"Goobie","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"2024101711414114000_8.4.00357-2022.22","doi-asserted-by":"crossref","first-page":"3562923","DOI":"10.1155\/2016\/3562923","article-title":"The Canadian registry for pulmonary fibrosis: design and rationale of a national pulmonary fibrosis registry","volume":"2016","author":"Ryerson","year":"2016","journal-title":"Can Respir J"},{"key":"2024101711414114000_8.4.00357-2022.23","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1093\/jamia\/ocab204","article-title":"An atomic approach to the design and implementation of a research data warehouse","volume":"29","author":"Visweswaran","year":"2022","journal-title":"J Am Med Informatics Assoc"},{"key":"2024101711414114000_8.4.00357-2022.24","unstructured":"Centre for Health Disparities Research, University of Wisconsin School of Medicine and Public Health. Neighborhood Atlas. Date last accessed: 13 May 2021. www.neighborhoodatlas.medicine.wisc.edu\/"},{"key":"2024101711414114000_8.4.00357-2022.25","unstructured":"Statistics Canada . The Canadian Index of Multiple Deprivation: User Guide. Accessed: September 28, 2019. https:\/\/www150.statcan.gc.ca\/n1\/pub\/45-20-0001\/452000012019002-eng.pdf"},{"key":"2024101711414114000_8.4.00357-2022.26","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.159.1.9712108"},{"key":"2024101711414114000_8.4.00357-2022.27","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.153.2.8564114"},{"key":"2024101711414114000_8.4.00357-2022.28","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00080312"},{"key":"2024101711414114000_8.4.00357-2022.29","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1377\/hlthaff.24.2.343","article-title":"Health disparities by race and class: why both matter","volume":"24","author":"Kawachi","year":"2005","journal-title":"Heal Aff"},{"key":"2024101711414114000_8.4.00357-2022.30","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1001\/jamainternmed.2021.2441","article-title":"Socioeconomic inequality in respiratory health in the US from 1959 to 2018","volume":"181","author":"Gaffney","year":"2021","journal-title":"JAMA Intern Med"},{"key":"2024101711414114000_8.4.00357-2022.31","unstructured":"Brookings Institution; Federal Reserve System. The Enduring Challenge of Concentrated Poverty in America: Case Studies from Communities across the U.S. Washington, The Federal Reserve System and The Brookings Institution, 2008."},{"key":"2024101711414114000_8.4.00357-2022.32","doi-asserted-by":"publisher","DOI":"10.1177\/1062860617753063"},{"key":"2024101711414114000_8.4.00357-2022.33","doi-asserted-by":"crossref","first-page":"e1915834","DOI":"10.1001\/jamanetworkopen.2019.15834","article-title":"Burden of cause-specific mortality associated with PM2.5 air pollution in the United States","volume":"2","author":"Bowe","year":"2019","journal-title":"JAMA Netw Open"},{"key":"2024101711414114000_8.4.00357-2022.34","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/MCP.0000000000000602","article-title":"Patient perspectives in sarcoidosis","volume":"25","author":"Van Helmondt","year":"2019","journal-title":"Curr Opin Pulm Med"},{"key":"2024101711414114000_8.4.00357-2022.35","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.chest.2017.11.030","article-title":"The pathogenesis of pulmonary sarcoidosis and implications for treatment","volume":"153","author":"Patterson","year":"2018","journal-title":"Chest"},{"key":"2024101711414114000_8.4.00357-2022.36","doi-asserted-by":"crossref","first-page":"3798","DOI":"10.3390\/ijerph16203798","article-title":"Neighborhood deprivation and risks of autoimmune disorders: a national cohort study in Sweden","volume":"16","author":"Li","year":"2019","journal-title":"Int J Env Res Public Heal"}],"container-title":["ERJ Open Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/23120541.00357-2022","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T05:21:23Z","timestamp":1740374483000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/23120541.00357-2022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":36,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,10,24]]},"published-print":{"date-parts":[[2022,10]]}},"alternative-id":["10.1183\/23120541.00357-2022"],"URL":"https:\/\/doi.org\/10.1183\/23120541.00357-2022","relation":{},"ISSN":["2312-0541"],"issn-type":[{"value":"2312-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10]]}}}